Seems like SA is on it's way out. Don't really care about the PRO charge, more importantly they have obviously done major restructuring with their Author Compensation. Very few if any articles on BioTech stocks since the 1st of the year. The only author's now publishing are info-commercials for their paid service with 1/4 of an article which make no sense......and other authors are leaving or thinking about leaving. I am definitely visiting less frequently.
Customer support service by UserEcho